FR273F - - Google Patents

Info

Publication number
FR273F
FR273F FR137029A FR137029A FR273F FR 273 F FR273 F FR 273F FR 137029 A FR137029 A FR 137029A FR 137029 A FR137029 A FR 137029A FR 273 F FR273 F FR 273F
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR137029A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR54503A external-priority patent/FR5422M/fr
Priority claimed from FR127218A external-priority patent/FR256F/fr
Application filed filed Critical
Priority to FR137029A priority Critical patent/FR273F/fr
Priority to US728880A priority patent/US3574688A/en
Application granted granted Critical
Publication of FR273F publication Critical patent/FR273F/fr
Priority to US00017855A priority patent/US3766248A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR137029A 1965-12-23 1968-01-23 Expired FR273F (mo)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR137029A FR273F (mo) 1965-12-23 1968-01-23
US728880A US3574688A (en) 1966-03-22 1968-05-14 Unsaturated 2-oxa steroid derivatives and process for their preparation
US00017855A US3766248A (en) 1966-03-22 1970-03-09 Substituted tricyclic compounds and process for their preparation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR43566 1965-12-23
FR54503A FR5422M (mo) 1965-12-23 1966-03-22
FR127218A FR256F (fr) 1965-12-23 1967-11-07 Nouveau médicament, notamment pour le traitement des troubles de l'anabolisme protidique, des manifestations de l'hypoandrogénie et de l'hyperfolliculine.
FR137029A FR273F (mo) 1965-12-23 1968-01-23

Publications (1)

Publication Number Publication Date
FR273F true FR273F (mo) 1969-10-06

Family

ID=39830197

Family Applications (1)

Application Number Title Priority Date Filing Date
FR137029A Expired FR273F (mo) 1965-12-23 1968-01-23

Country Status (1)

Country Link
FR (1) FR273F (mo)

Similar Documents

Publication Publication Date Title
JPS4325006Y1 (mo)
JPS42633Y1 (mo)
JPS414571Y1 (mo)
BE674891A (mo)
BE674418A (mo)
BE666227A (mo)
BE670383A (mo)
SE309948B (mo)
BE674937A (mo)
BE674323A (mo)
LU49664A1 (mo)
NL6615637A (mo)
BE673712A (mo)
BE675101A (mo)
BE675149A (mo)
BE674531A (mo)
BE662383A (mo)
NL6506557A (mo)
BE674845A (mo)
BE674821A (mo)
BE675070A (mo)
NL6603945A (mo)
BE674726A (mo)
BE674825A (mo)
BE675140A (mo)